# GPC3-CAR-T Cells for the Hepatocellular Carcinoma

> **NCT04506983** · PHASE1 · SUSPENDED · sponsor: **Beijing Tsinghua Chang Gung Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **BIOLOGICAL:** GPC3-CAR-T cells

## Key facts

- **NCT ID:** NCT04506983
- **Lead sponsor:** Beijing Tsinghua Chang Gung Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2022-06-10
- **Primary completion:** 2023-06-10
- **Final completion:** 2023-10-10
- **Target enrollment:** 12 (ESTIMATED)
- **Why stopped:** Adjust the plan
- **Last updated:** 2022-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04506983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04506983, "GPC3-CAR-T Cells for the Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04506983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*